Pennant Group [PNTG] vs HCA Healthcare [HCA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Pennant Group, Inc. wins in 8 metrics, HCA Healthcare Inc. wins in 12 metrics, with 0 ties. HCA Healthcare Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pennant Group, Inc. HCA Healthcare Inc. Better
P/E Ratio (TTM) 34.94 16.86 HCA Healthcare Inc.
Price-to-Book Ratio 3.08 -38.44 Pennant Group, Inc.
Debt-to-Equity Ratio 122.87 -17.57 Pennant Group, Inc.
PEG Ratio 0.74 0.37 HCA Healthcare Inc.
EV/EBITDA 24.80 10.08 HCA Healthcare Inc.
Profit Margin (TTM) 3.12% 8.97% HCA Healthcare Inc.
Operating Margin (TTM) 6.25% 16.29% HCA Healthcare Inc.
EBITDA Margin (TTM) 6.25% 16.29% HCA Healthcare Inc.
Return on Equity 9.84% -244.82% Pennant Group, Inc.
Return on Assets (TTM) 3.90% 12.44% HCA Healthcare Inc.
Free Cash Flow (TTM) $36.26M $7.69B HCA Healthcare Inc.
Dividend Yield N/A 0.59% N/A
1-Year Return 19.30% -0.75% Pennant Group, Inc.
Price-to-Sales Ratio (TTM) 1.07 1.39 Pennant Group, Inc.
Enterprise Value $1.49B $156.18B HCA Healthcare Inc.
EV/Revenue Ratio 1.57 2.07 Pennant Group, Inc.
Gross Profit Margin (TTM) 13.57% 41.90% HCA Healthcare Inc.
Revenue per Share (TTM) $27 $320 HCA Healthcare Inc.
Earnings per Share (Diluted) $0.84 $27.94 HCA Healthcare Inc.
Beta (Stock Volatility) 1.30 1.37 Pennant Group, Inc.
Short % of Float 2.42% 2.45% Pennant Group, Inc.

Pennant Group, Inc. vs HCA Healthcare Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pennant Group, Inc.-0.76%-10.74%-2.41%-8.09%4.37%9.05%
HCA Healthcare Inc.-0.39%-7.37%-14.97%-32.96%-25.38%-22.78%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pennant Group, Inc.19.30%176.21%1.75%114.06%114.06%114.06%
HCA Healthcare Inc.-0.75%38.02%77.08%384.44%1,008.79%1,116.39%

Performance & Financial Health Analysis: Pennant Group, Inc. vs HCA Healthcare Inc.

MetricPNTGHCA
Market Information
Market Cap i$1.05B$106.00B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i152,152795,641
90 Day Avg. Volume i226,704974,074
Last Close$30.12$361.83
52 Week Range$21.73 - $37.54$330.00 - $556.52
% from 52W High-19.77%-34.98%
All-Time High$69.56 (Jan 04, 2021)$556.52 (Mar 12, 2026)
% from All-Time High-56.70%-34.98%
Growth Metrics
Quarterly Revenue Growth0.53%0.07%
Quarterly Earnings Growth0.50%0.31%
Financial Health
Profit Margin (TTM) i0.03%0.09%
Operating Margin (TTM) i0.06%0.16%
Return on Equity (TTM) i0.10%-2.45%
Debt to Equity (MRQ) i122.87-17.57
Cash & Liquidity
Book Value per Share (MRQ)$9.54$-26.83
Cash per Share (MRQ)$0.49$5.11
Operating Cash Flow (TTM) i$48.29M$12.64B
Levered Free Cash Flow (TTM) i$7.21M$5.82B
Dividends
Last 12-Month Dividend Yield iN/A0.59%
Last 12-Month Dividend iN/A$2.94

Valuation & Enterprise Metrics Analysis: Pennant Group, Inc. vs HCA Healthcare Inc.

MetricPNTG (Apr 24, 2026)HCA (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i34.9416.86
Forward P/E i18.7114.13
PEG Ratio i0.740.37
Price to Sales (TTM) i1.071.39
Price to Book (MRQ) i3.08-38.44
Market Capitalization
Market Capitalization i$1.05B$106.00B
Enterprise Value i$1.49B$156.18B
Enterprise Value Metrics
Enterprise to Revenue i1.572.07
Enterprise to EBITDA i24.8010.08
Risk & Other Metrics
Beta i1.301.37
Book Value per Share (MRQ) i$9.54$-26.83

Financial Statements Comparison: Pennant Group, Inc. vs HCA Healthcare Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPNTG (2025)HCA (2025)
Revenue/Sales i947.71M75.60B
Cost of Goods Sold i817.20M44.23B
COGS % of Revenue i86.2%58.5%
Gross Profit i130.50M31.37B
Gross Margin i13.8%41.5%
Research & Development iN/AN/A
Operating Income (EBIT) i50.89M11.97B
Operating Margin i5.4%15.8%
EBITDA i59.85M15.57B
EBITDA Margin i6.3%20.6%
Pre-Tax Income i45.63M9.83B
Pre-Tax Income % of Revenue i4.8%13.0%
Income Tax i11.87M2.05B
Income Tax % of Revenue i1.3%2.7%
Net Income (Profit) i33.76M7.78B
Profit Margin i3.6%10.3%

Balance Sheet & Liquidity Metrics

MetricPNTG (2025)HCA (2025)
Cash & Equivalents i17.02M1.04B
Total Current Assets i167.41M15.78B
Total Current Assets % of Revenue i17.7%20.9%
Total Current Liabilities i147.26M16.35B
Total Current Liabilities % of Revenue i15.5%21.6%
Long-Term Debt i423.15M43.46B
Long-Term Debt % of Revenue i44.6%57.5%
Total Shareholders Equity i374.25M-2.77B
Retained Earnings i86.80M-5.72B
Retained Earnings % of Revenue i9.2%-7.6%
Property, Plant & Equipment i313.64M39.12B

Cash Flow Statement Comparison

MetricPNTG (2025)HCA (2025)
Operating Cash Flow i33.89M12.01B
Operating Cash Flow % of Revenue i3.6%15.9%
Capital Expenditures i-12.04M-4.94B
Free Cash Flow i36.26M7.69B
FCF Margin i3.8%10.2%
Debt Repayment i-298.00M-7.39B
Common Stock Repurchase iN/A-10.07B

Short Interest & Institutional Ownership Analysis

MetricPNTGHCA
Shares Short i797,4563.63M
Short Ratio i3.003.37
Short % of Float i2.42%2.45%
Shares Outstanding i34.63M224.61M
Float Shares i33.00M151.19M
% Held by Insiders i5.00%16.16%
% Held by Institutions i97.01%78.70%
% Held by Public i-2.01%5.14%

Dividend Analysis & Yield Comparison: Pennant Group, Inc. vs HCA Healthcare Inc.

MetricPNTGHCA
Last 12-Month Dividend iN/A$2.94
Last 12-Month Dividend Yield iN/A0.59%
3-Year Avg Annual Dividend iN/A$2.70
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$8.10
Ex-Dividend DateN/AMar 17, 2026